Back to Search

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd


  • Protocol Number: 202105154
  • Principal Investigator: Bagegni, Nusayba
  • Cancer Types:

For more information on this trial, contact us here:

Phone
800-600-3606
Email
info@ccadmin.wustl.edu

Brief Summary

Protocol Interventions